Literature DB >> 32268088

Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.

Melissa B Uccellini1, Susana V Bardina2, Maria Teresa Sánchez-Aparicio1, Kris M White1, Ying-Ju Hou3, Jean K Lim2, Adolfo García-Sastre4.   

Abstract

The Toll/IL-1R-domain-containing adaptor protein SARM1 is expressed primarily in the brain, where it mediates axonal degeneration. Roles for SARM1 in TLR signaling, viral infection, inflammasome activation, and chemokine and Xaf1 expression have also been described. Much of the evidence for SARM1 function relies on SARM1-deficient mice generated in 129 ESCs and backcrossed to B6. The Sarm1 gene lies in a gene-rich region encompassing Xaf1 and chemokine loci, which remain 129 in sequence. We therefore generated additional knockout strains on the B6 background, confirming the role of SARM1 in axonal degeneration and WNV infection, but not in VSV or LACV infection, or in chemokine or Xaf1 expression. Sequence variation in proapoptotic Xaf1 between B6 and 129 results in coding changes and distinct splice variants, which may account for phenotypes previously attributed to SARM1. Reevaluation of phenotypes in these strains will be critical for understanding the function of SARM1.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SARM1; TLR signaling; Wallerian degeneration; Xaf1; chemokines; viral infection

Mesh:

Substances:

Year:  2020        PMID: 32268088      PMCID: PMC7226674          DOI: 10.1016/j.celrep.2020.03.062

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

Review 1.  Genetic determinants of the virulence and infectivity of La Crosse virus.

Authors:  F Gonzalez-Scarano; B Beaty; D Sundin; R Janssen; M J Endres; N Nathanson
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

2.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

3.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

4.  XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.

Authors:  Min-Goo Lee; Jikhyon Han; Seong-In Jeong; Nam-Gu Her; Jin-Hee Lee; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

5.  Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation.

Authors:  Chih-Yuan Chiang; Ville Veckman; Kirsten Limmer; Michael David
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

6.  SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter.

Authors:  Claudia Gürtler; Michael Carty; Jay Kearney; Stefan A Schattgen; Aihao Ding; Katherine A Fitzgerald; Andrew G Bowie
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

7.  Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response.

Authors:  Nicole T Liberati; Katherine A Fitzgerald; Dennis H Kim; Rhonda Feinbaum; Douglas T Golenbock; Frederick M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-27       Impact factor: 11.205

8.  TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.

Authors:  Carole Couillault; Nathalie Pujol; Jérôme Reboul; Laurence Sabatier; Jean-François Guichou; Yuji Kohara; Jonathan J Ewbank
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

9.  SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease.

Authors:  Caihong Zhu; Bei Li; Karl Frontzek; Yingjun Liu; Adriano Aguzzi
Journal:  J Exp Med       Date:  2019-03-06       Impact factor: 14.307

10.  MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival.

Authors:  Younghwa Kim; Ping Zhou; Liping Qian; Jen-Zen Chuang; Jessica Lee; Chenjian Li; Costantino Iadecola; Carl Nathan; Aihao Ding
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

View more
  12 in total

Review 1.  NAD+ metabolism and its roles in cellular processes during ageing.

Authors:  Anthony J Covarrubias; Rosalba Perrone; Alessia Grozio; Eric Verdin
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

Review 2.  SARM1 can be a potential therapeutic target for spinal cord injury.

Authors:  Qicheng Lu; Benson O A Botchway; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Cell Mol Life Sci       Date:  2022-02-28       Impact factor: 9.261

Review 3.  Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.

Authors:  Gregory Hook; Thomas Reinheckel; Junjun Ni; Zhou Wu; Mark Kindy; Christoph Peters; Vivian Hook
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

4.  Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.

Authors:  Donald V Bradshaw; Andrew K Knutsen; Alexandru Korotcov; Genevieve M Sullivan; Kryslaine L Radomski; Bernard J Dardzinski; Xiaomei Zi; Dennis P McDaniel; Regina C Armstrong
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

Review 5.  A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.

Authors:  Eleanor L Hopkins; Weixi Gu; Bostjan Kobe; Michael P Coleman
Journal:  Front Mol Biosci       Date:  2021-07-08

6.  SARM1 Promotes Photoreceptor Degeneration in an Oxidative Stress Model of Retinal Degeneration.

Authors:  Luke Gibbons; Ema Ozaki; Chris Greene; Anne Trappe; Michael Carty; Judith A Coppinger; Andrew G Bowie; Matthew Campbell; Sarah L Doyle
Journal:  Front Neurosci       Date:  2022-04-01       Impact factor: 5.152

7.  Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.

Authors:  Kenneth Viar; Daniel Njoku; Julie Secor McVoy; Unsong Oh
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

8.  Structural basis for SARM1 inhibition and activation under energetic stress.

Authors:  Michael Sporny; Julia Guez-Haddad; Tami Khazma; Carsten Mim; Michail N Isupov; Ran Zalk; Michael Hons; Avraham Yaron; Moshe Dessau; Yoel Shkolnisky; Yarden Opatowsky
Journal:  Elife       Date:  2020-11-13       Impact factor: 8.140

9.  Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity.

Authors:  Martin Weber; Sang-Won Min; Oded Foreman; Abdoulaye Sene; Baris Bingol; Tom Truong; Jeffrey Hung; Stephanie Dale; Mike Reichelt; Savita Ubhayakar; Carol Cain-Hom; Miriam Baca; Zhiyu Jiang; Qingling Li; Robert Brendza; Han Lin; Chung Kung; William F Forrest; Cristine Quiason-Huynh; Wendy Sandoval; Buyun Chen; Yuzhong Deng; Amy Easton
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

10.  Genetic targeting of Card19 is linked to disrupted NINJ1 expression, impaired cell lysis, and increased susceptibility to Yersinia infection.

Authors:  Elisabet Bjanes; Reyna Garcia Sillas; Rina Matsuda; Benjamin Demarco; Timothée Fettrelet; Alexandra A DeLaney; Opher S Kornfeld; Bettina L Lee; Eric M Rodríguez López; Daniel Grubaugh; Meghan A Wynosky-Dolfi; Naomi H Philip; Elise Krespan; Dorothy Tovar; Leonel Joannas; Daniel P Beiting; Jorge Henao-Mejia; Brian C Schaefer; Kaiwen W Chen; Petr Broz; Igor E Brodsky
Journal:  PLoS Pathog       Date:  2021-10-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.